305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy

BACKGROUND: Piperacillin-tazobactam (TZP) is common empiric and targeted therapy for gram-negative bacteremia in patients with hematologic malignancy. Resistance to TZP tends to occur concurrently with ceftriaxone (CRO) resistance; however, the prevalence of TZP nonsusceptibility in CRO susceptible...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Main Authors: Spitznogle, Sarah L, Rausch, Caitlin R, Bhatti, Micah M, Shelburne, Samuel A, Aitken, Samuel L
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Poster Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776808/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.348
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares